Baclofen: uses, dosing, side effects & brands

LYVISPAH (baclofen) oral granules is a gamma-aminobutyric acid (GABA-ergic) agonist available as 5 mg, 10 mg, or 20 mg of baclofen oral granules in a packet.

The FDA classifies baclofen as a gamma-aminobutyric acid-ergic agonist. If you are checking whether it is safe to combine with something else, the class is what matters — two drugs from the same class usually should not be stacked.

The label's Precautions section warns that the central nervous system effects of baclofen may be additive to those of alcohol and other CNS depressants. In other words, combining baclofen with alcohol can compound sedation and drowsiness. This is an additive-CNS-depression caution, not a disulfiram-like reaction. This is what baclofen's FDA label says; alcohol advice depends on your dose and health, so confirm with your pharmacist.

The label's Warnings section ("Abrupt Drug Withdrawal") states that hallucinations and seizures have occurred on abrupt withdrawal of baclofen. It directs that, except for serious adverse reactions, the dose should be reduced slowly when the drug is discontinued, and the Dosage and Administration section reiterates that patients should be slowly withdrawn from the drug. This is a prescriber-managed taper; it is a labeled warning but not part of a boxed warning. Do not stop baclofen on your own — any change is a prescriber-managed decision.

The elimination half-life of baclofen is about 5.7 hours — that is how long the body takes to clear half of a dose. This is the apparent elimination half-life of the parent drug. Baclofen is not a prodrug and has no active metabolite that outlasts it — the label states it is excreted primarily by the kidney in unchanged form, so the half-life reflects renal clearance directly. Because of that, elimination is slower in people with reduced kidney function (renal impairment) and in older adults, in whom the drug can accumulate and the dose may need to be reduced. The label also notes large intersubject variation in absorption and/or elimination, so individual half-life can differ. Half-life is not the same as a drug-test detection window: baclofen is essentially cleared within about 72 hours of a dose, but detectability depends on the test. Half-life is not the same as how long a drug test can detect the drug, and it varies with age, kidney and liver function.

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run baclofen against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

We track 7 baclofen-containing products in the U.S.: Kemstro, Lioresal, Lyvispah, Baclofen, Gablofen, Ozobax and Ozobax Ds. They are the same active ingredient; they differ in form, manufacturer, price and FDA recall record.

Across the brands we track, baclofen is currently marketed as tablet, orally disintegrating, injectable, tablet, powder, solution and suspension, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Yes. Our catalog lists 1 generic baclofen product alongside the brand versions. A generic has the same active ingredient and must meet the FDA's bioequivalence standard; it usually costs less. Ask your pharmacist which one your plan covers.

The FDA's Enforcement database lists 1 recall record whose product description mentions baclofen. The most recent: Baclofen Tablets USP (Nov 26, 2025). A recall applies to specific lots, not to the drug as a whole — check the record for the affected lot numbers.

Alcohol: the FDA label flags alcohol as something to be careful with — see the alcohol section above for what it actually says. This is what the FDA label and our cited sources say — it is not a complete list. Your pharmacist can check your own combination.

Drowsiness is the most common, along with dizziness, weakness, fatigue, nausea and sometimes confusion. These are dose-related and usually heaviest in the first days after a start or a dose increase, which is exactly why baclofen is titrated up slowly rather than started at a full dose. Most people find the sedation settles over one to two weeks at a steady dose. Taking it with food helps the nausea. Don't drive or operate machinery until you know how it affects you, and expect a fresh wave of drowsiness after every dose increase, not just the first one.

Abrupt discontinuation of baclofen has caused hallucinations and seizures — that warning is on the oral label. The label's fuller description of the withdrawal syndrome also includes high fever, altered mental status, exaggerated rebound spasticity and muscle rigidity, which in rare cases has advanced to rhabdomyolysis, multiple organ-system failure and death. That severe end of the spectrum is best known from intrathecal baclofen pumps, where it carries a boxed warning, but the oral label carries the same language and the same instruction: reduce the dosage slowly unless the clinical situation justifies rapid withdrawal. Don't let prescriptions lapse, and if you're hospitalized, make sure the team knows you take it.

Call 911 or go to an ER for a seizure, hallucinations or new severe confusion, unresponsiveness or extreme sleepiness, or slow and shallow breathing. Call your doctor promptly for progressive confusion, slurred speech or increasing daytime sleepiness that doesn't match your dose. Kidney function is the hidden variable: baclofen is excreted primarily unchanged by the kidneys, so reduced kidney function lets it accumulate, and the label calls for caution and says a dosage reduction may be necessary. In people with chronic kidney disease or on dialysis, a standard dose can build up into confusion, deep sedation or coma. Baclofen should also be used with caution if you have epilepsy — worsening seizure control has been reported.

Alcohol, opioids, benzodiazepines, gabapentin, pregabalin, other muscle relaxants and sedating antihistamines all stack on top of baclofen's sedation. Combining them is the usual reason a stable dose suddenly feels overwhelming. The weakness issue is subtler and worth planning for: baclofen works by reducing muscle tone, and some people rely on that stiffness to stand, transfer or walk — the label specifically flags patients who use spasticity to sustain upright posture and balance. If stiffness is doing structural work for you, loosening it can make mobility worse, not better. Track whether your walking, transfers and balance improve or decline over the first few weeks, and bring that specific observation back to the prescriber.

Baclofen is a muscle relaxant FDA-approved to treat spasticity — muscle tightness, stiffness, and spasms — caused by multiple sclerosis and by spinal cord injuries or diseases. It works on the spinal cord to reduce the number and severity of muscle spasms and can ease related pain. It comes as tablets and, for severe cases, as an implanted pump (intrathecal).

Yes. Baclofen is prescribed off-label for alcohol use disorder to reduce cravings, for persistent hiccups, and sometimes for GERD-related symptoms or muscle spasms from other causes. These uses are not FDA-approved, and the evidence for alcohol use disorder in particular is mixed and still debated.

No — stopping baclofen abruptly, especially after long-term or high-dose use, can cause serious withdrawal including hallucinations, seizures, high fever, and muscle rigidity, which can be life-threatening. The dose should always be lowered gradually under a doctor's supervision. Common everyday side effects are drowsiness, weakness, and dizziness.